The rise in women getting double mastectomies after a breast cancer diagnosis could be linked to anxiety and breast MRI, as reported by NPR on May 21.

Review of CT scout view can unveil significant pathologic findings not included in the CT field of view (FOV), which is especially important for the detection of pathologic findings in anatomic findings that are not imaged by CT, according to a study published in the June issue of the American Journal of Roentgenology.

Tau has been identified as one of the keys to unlocking neurodegenerative disease, including Alzheimer’s. However, efforts to develop an ideal tau PET agent continue to be an uphill battle, according to a review published May 15 in the Journal of Nuclear Medicine.

A minimally invasive PET scan could tell clinicians about a patient’s exocrine function without all of the usual pains of conventional testing, according to a study published May 19 in the Journal of Nuclear Medicine.

In this video, BBC reporter Fergus Walsh is the first to undergo an MRI scan as part of the largest scan study to date and describes how the study is evolving.

IBA Molecular North America, Inc. (IBA Molecular) announced the signing of a 3-year group purchasing agreement with Premier, Inc. (Premier), a leading health care improvement company, to offer PET radiopharmaceuticals, including 18F-Fluorodeoxyglucose (FDG), a diagnostic radiotracer used in oncology, neurology and cardiology, to Premier member imaging centers across the country.

An estimated 100,000 participants are expected to get involved in a major effort to understand the pathology of dementia. Medical research institute UK Biobank is planning to image 9,000 cases of Alzheimer’s disease by 2022.

Successful identification of patients using surface-rendered faces may be a relatively difficult task for observers, according to a study published in the June issue of the American Journal of Roentgenology.